![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright Yang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Dynein-Dynactin Complex Is Essential for Dendritic Restriction of TM1-Containing Drosophila Dscam 1Department of Neurobiology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America 2Neuroscience Program, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America Frederic Andre Meunier, Editor The University of Queensland, Australia * E-mail: Tzumin.Lee/at/umassmed.edu Conceived and designed the experiments: JSJY TL. Performed the experiments: JSJY JMB. Analyzed the data: JSJY TL. Contributed reagents/materials/analysis tools: JSJY. Wrote the paper: JSJY TL. Received July 30, 2008; Accepted September 29, 2008. Abstract Background Many membrane proteins, including Drosophila Dscam, are enriched in dendrites or axons within neurons. However, little is known about how the differential distribution is established and maintained. Methodology/Principal Findings Here we investigated the mechanisms underlying the dendritic targeting of Dscam[TM1]. Through forward genetic mosaic screens and by silencing specific genes via targeted RNAi, we found that several genes, encoding various components of the dynein-dynactin complex, are required for restricting Dscam[TM1] to the mushroom body dendrites. In contrast, compromising dynein/dynactin function did not affect dendritic targeting of two other dendritic markers, Nod and Rdl. Tracing newly synthesized Dscam[TM1] further revealed that compromising dynein/dynactin function did not affect the initial dendritic targeting of Dscam[TM1], but disrupted the maintenance of its restriction to dendrites. Conclusions/Significance The results of this study suggest multiple mechanisms of dendritic protein targeting. Notably, dynein-dynactin plays a role in excluding dendritic Dscam, but not Rdl, from axons by retrograde transport. Introduction Neurons exhibit highly polarized structures, including two morphologically and functionally distinct domains, axons and dendrites. Dendrites and axons respectively receive or send information, proper execution of which requires different sets of molecules. For example, in the mammalian brain and in cultured neurons, voltage-gated potassium channels of the Kv1 (Shaker) family reside in the axons. In contrast, voltage-gated potassium channel Kv2.1 and Kv2.2 are selectively enriched in the somatodendritic region [1]–[3]. The dendritic potassium channels undergo slower inactivation to prevent back-propagation of action potentials into the dendrites [4], [5]. Certain metabotropic glutamate receptors, including mGluR1a and mGluR2, also show polarized distribution [6], and potentially underlie differential glutamate effects in different compartments of neurons [7], [8]. One dominant model to explain the differential distribution of neuronal membrane proteins involves directed transport of vesicular cargos along the microtubules that extend into the dendrites and axons [9]. Microtubules have polarity; directed transport requires motors to move cargos toward the plus- or minus-end of the microtubules. In axons microtubules are uniformly oriented with minus-ends pointing to the cell body, while microtubules exist with mixed polarity within the somatodendritic region [10]. This difference in microtubule organization supports the hypothesis that minus-end-directed motors are constantly moving molecules out of axons and may selectively transport their cargos into the dendrites [11]. Identified minus-end-directed motors include dynein and C-terminal kinesins. Cytoplasmic dynein, which forms a large complex with its activator dynactin, is responsible for the retrograde transport in axons [12], [13]. Dynein/dynactin complex contains more than twenty subunits. Although the functions of each subunit remain to be determined, it is believed that all the subunits act together to regulate the processivity and cargo-binding selectivity of dynein [13], [14]. Various C-terminal kinesins (i.e. Ncd in Drosophila and KIFC2 in mouse), which carry their motor domain at the C-terminus, also move specifically toward the minus end. But their real function in vesicular transport is unclear [15], [16]. The role of minus-end-directed motors in dendritic protein targeting remains undocumented. Besides selective transport, additional mechanisms may contribute to the polarized distribution by differential depletion or stabilization. For example, the steady-state axonal distribution of Nav1.2 and VAMP2 is primarily achieved through their selective removal by endocytosis from the dendritic plasma membrane [17], [18]. Preferential fusion of vesicular cargos with different plasma membrane domains may mediate some polarized distribution as well. One precedent for fusion selectivity involves targeting of distinct SNAREs to the apical or basolateral domains of epithelial MDCK cells [19]. Other possible mechanisms include existence of diffusion barriers and/or protein stabilization by scaffold proteins. However, most of these studies shed light on the polarized distribution of axonal proteins; and little is known about dendritic protein targeting [6], [20], [21]. Drosophila Down Syndrome cell adhesion molecule (Dscam) is a transmembrane protein, which belongs to the immunoglobulin (Ig) superfamily. Dscam is essential for diverse neuronal morphogenetic processes, including axon guidance, branch segregation, and dendritogenesis [22]–[25]. Notably, Drosophila Dscam can encode thousands of isoforms through alternative splicing involving many choices of exon 4, 6, 9 and 17. Distinct Dscam isoforms may be targeted to dendrites or axons, depending on which of the two transmembrane-domain-encoding exon 17 alternatives, 17.1 or 17.2, is utilized [26]. Dscam isoforms carrying exon 17.1 (Dscam[TM1]) are largely restricted to dendrites, while Dscam isoforms with exon 17.2 (Dscam[TM2]) are enriched in axons. Further, depleting Dscam[TM1] or Dscam[TM2] blocks morphogenesis of dendrites versus axons [27]. Understanding how isoforms of Dscam are differentially distributed in neurons promises to shed new light on neuron polarity and its underlying mechanisms. Here we performed genetic mosaic screens to identify genes required cell-autonomously for the dendritic targeting of Dscam[TM1]. We obtained mutants that exhibit different mislocalization phenotypes. We identified three mutations in the known components of dynein-dynactin complex (Lis1, p24 and Dynamitin) that all affect Dscam dendritic targeting. Misdistribution of dendritic Dscam to axons was also observed when we suppressed the expression of other dynein/dynactin components with RNA interference. However, microtubule polarity in the mutant axons was maintained. Transient induction of Dscam[TM1] further revealed that disrupting dynein/dynactin function did not affect the targeting of newly synthesized Dscam[TM1] to the dendrites. Instead, dendritic Dscam later diffused into the axons. These observations indicate that dynein/dynactin plays a role in maintaining dendritic restriction of Dscam[TM1], and further suggest a dynein/dynactin-independent mechanism for the initial targeting of Dscam[TM1] to dendrites. Notably, dynein/dynactin dysfunction did not alter distribution of another dendritic transmembrane protein Rdl (Resistant to Dieldrin), supporting involvement of diverse mechanisms in locating distinct molecules to the dendritic membrane. Results Drosophila Dscam[TM1] as a dendritic marker for genetic mosaic analysis of dendritic protein targeting We have previously shown that transgenic Dscam carrying the exon 17.1-encoding transmembrane domain (referred to as Dscam[TM1] as opposed to Dscam[TM2] that carries exon 17.2) is selectively targeted to dendrites. When ectopically expressed in the neurons of the Drosophila olfactory learning and memory center, the mushroom bodies (MBs), Dscam[TM1]::GFP exists abundantly in the calyx where MB dendrites are located, but could not be detected in the axons which extend through the peduncle before entering the MB lobes (Figures 1B, 1C and 1H
To adapt the system for genetic mosaic screens on dendritic protein targeting, we incorporated UAS-mCD8::RFP and UAS-Dscam[TM1]::GFP into MARCM (Figure 1A Analysis of mutants that exhibited aberrant accumulation of Dscam[TM1]::GFP in axons Detailed analysis of group 1 mutants further revealed subclasses of misdistribution phenotypes. Five of the nine mutants exhibited granular accumulation of Dscam[TM1]::GFP in the MB lobes (e.g. Figures 2A–2C and 2G
Complementation among the mutations yielded six complementation groups. Mapping against deficiency lines and other known mutations further revealed that mutations in Lis1, p24, and Dynamitin (Dmn) constituted three of the four complementation groups which showed mistargeted Dscam[TM1]::GFP in granules (Figures 2A–2C Requirement of dynein-dynactin complex for the restriction of Dscam[TM1]::GFP to dendrites In order to substantiate the involvement of dynein-dynactin complex, we first confirmed that Lis1, Dmn, and p24 are required for the dendritic restriction of Dscam[TM1]::GFP using reagents independent of our genetic screen. Genes could be effectively silenced in the MBs by RNA interference (RNAi) [27], [40]; and transgenic flies carrying UAS-RNAi against various Drosophila genes, including Lis1, Dmn, and many other components of dynein-dynactin complex, are available in the Vienna Drosophila RNAi Center (VDRC) [41]. Encouragingly, silencing Lis1 or Dmn, as opposed to various control genes (such as CG8446 and CG18247), by targeted RNAi effectively mislocalized transgenic Dscam[TM1]::GFP to MB axon lobes (Figures 3A–3C
Further, we knocked down additional components of the dynein/dynactin complex (Figure 3J In addition, the role of Glued was determined through inhibition of its function by a dominant-negative Glued (GlΔ) [42]. Glued is the largest subunit of dynactin complex and plays a particular important role in dynein binding and enhancement of dynein processivity. Overexpression of C-terminal-truncated Glued (GlΔ), known to dominantly block dynein/dynactin function, also resulted in axonal accumulation of dendritic Dscam, especially near the ends of axonal lobes (Figures 4A and 4B
Blocking dynein/dynactin function does not affect dendritic targeting of two other dendritic markers To determine how broadly dynein/dynactin is involved in dendritic protein targeting, we examined whether dynein/dynactin is required for proper localization of other dendritic proteins. Several documented dendritic markers, including homer-GFP, Apc2-GFP, Act5C-GFP, Nod- β -gal and Rdl-HA [43], [44], were ectopically expressed in the larval MBs using GAL4-201Y as the driver. In this condition, only Nod-β-gal and Rdl-HA showed predominant somatodendritic distribution and were largely excluded from MB axon lobes (Figures 4E and 4C Nod-β-gal is a fusion protein comprised of the motor domain of Nod and β-galactosidase, and has been shown to be a reliable minus-end reporter for microtubules in Drosophila, including MB neurons [45]–[47]. Consistent with the notion that microtubules are uniformly oriented with plus-end pointing distally in axons, Nod-β-gal was highly enriched in dendrites and cell bodies but largely absent from peduncles and axonal lobes in wild-type MB neurons (Figure 4E
Rdl-HA (Resistant to Dieldrin) is a GABA receptor tagged with the HA epitope, and has been shown to be well restricted to dendrites in Drosophila embryonic motor neurons [44]. In wild-type MB neurons, Rdl-HA was also localized in dendrites and cell bodies, and proximal region of peduncles only (Figure 4C Retrograde transport plays a role in maintaining but not establishing Dscam[TM1] dendritic restriction We wondered how dynein/dynactin complexes act to ensure restriction of Dscam[TM1] to the dendrites. As a minus-end-directed microtubule motor, dynein/dynactin may actively move Dscam[TM1] from cell bodies to dendrites by selective transport. Alternatively, it may play a scavenging role and constantly remove mistargeted Dscam[TM1] out of axons via retrograde axonal transport [11], [48], [49]. To distinguish between these two possibilities, we sought to visualize newly synthesized Dscam[TM1]::GFP and examine how dynein/dynactin dysfunction might affect the initial sorting of Dscam[TM1] and/or the maintenance of its dendritic distribution. Transient induction of Dscam[TM1]::GFP in the larval MBs was achieved using the TARGET system, in which GAL4-dependent expression of UAS-transgene is acutely controlled by a temperature-sensitive GAL4 repressor, GAL80ts [50]. At 18°C, GAL4-OK107 was fully suppressed by GAL80ts (Figure 6A and 6C
We next co-expressed dominant-negative Glued to determine how compromised dynein/dynactin function might affect the sorting of newly synthesized Dscam[TM1]::GFP. Analogous transient co-induction did not alter the dendritic distribution of Dscam[TM1]::GFP (data not shown, similar to Figure 6E Two possible scenarios may underlie the time course of mislocalization. First, several hours of continuous induction might be needed to express enough truncated Glued for blocking dynein/dynactin function. Second, dynein/dynactin could be dispensable to the selective transport of Dscam[TM1] from cell bodies to dendrites, and specifically involved in removing any mistargeted Dscam[TM1] out of the axons. In this case, blocking dynein/dynactin function should not affect the initial dendritic targeting of Dscam[TM1]::GFP, but would compromise the ability of neurons to promptly move Dscam[TM1]::GFP from the axon ‘hillock’ back to the somatodendritic region. To determine if such a protracted process of misdistribution occurred as a consequence of slow accumulation of dominant-negative Glued, we further examined how increasing the dosage of dominant-negative Glued affects the misdistribution process [52]. We could drastically shorten the time to detect mCD8::GFP in TARGET by doubling the copy number of UAS transgene (data not shown). If induction of dominant-negative Glued was the rate-limiting factor, increasing the dosage of truncated Glued should accelerate the onset of mistargeting. As the copy number of UAS- GlΔ transgene was increased to two and even three, we did not detect any change in the profile of the slow-onset, gradual accumulation of Dscam[TM1]::GFP in the MB axons (Figure 6M In summary, these pulse-induction experiments ascribe a primary role to the mechanism of selective transport in the dendritic targeting of Dscam[TM1]. This explains why newly synthesized Dscam[TM1] can be promptly located to dendrites, showing no evidence for incidental mistargeting. However, trace amounts of Dscam[TM1] may distribute to axons. It never accumulates to a detectable level in axons with intact dynein/dynactin function. Dynein/dynactin mediates retrograde axonal transport which apparently plays a scavenger role in the restriction of Dscam[TM1] to dendrites. Discussion Multiple lines of evidence indicate that the dynein/dynactin complex has an important function in maintaining proper distribution of dendritic Dscam in MB neurons. First, mutations in three components (Lis1, Dmn and p24) of the dynein/dynactin complex were recovered based on mislocalization of dendritic Dscam through a MARCM-based genetic mosaic screen (Figures 2A–2C Acute induction by TARGET revealed two mechanisms underlying the dendritic distribution of Dscam[TM1]. Newly synthesized Dscam[TM1] was largely excluded from axons, suggesting directed dendritic targeting and the involvement of selective transport in the dendritic distribution of Dscam[TM1]. Though dynein/dynactin is essential for restricting Dscam[TM1] to dendrites, knocking down dynein/dynactin function did not disrupt the directed dendritic targeting. This leads us to believe that dynein/dynactin is required for preventing dendritic Dscam from misdistributing into axons. When dynein/dynaction function was compromised, newly synthesized Dscam[TM1] remained consistently targeted to dendrites but later leaked into axons. Dendritic Dscam gradually filled the axons; and it took about six hours for Dscam[TM1] to reach the axon termini. This protracted process of mislocalization suggests that dendritic Dscam passively leaks into the axons, and that dynein/dynactin-mediated retrograde axonal transport normally acts to rapidly move leaked Dscam[TM1]-containing vesicles out of the axons. In summary, these phenomena not only demonstrate a dynein-dynactin-independent mechanism of selective transport that preferentially targets Dscam[TM1]-containing vesicles to dendrites, but also implicate the involvement of retrograde axonal transport in preventing accumulation of Dscam[TM1] in axons. These two independent mechanisms act together to ensure restriction of dendritic Dscam to the dendrites. Although the dynein/dynactin complex is essential for maintaining dendritic distribution of Dscam[TM1], our results do not reveal whether mislocalized Dscam[TM1] is on the plasma membrane or in vesicles inside the cytoplasm. It is possible that dendritic Dscam passively leaks into axons either through membrane diffusion or mistargeting of vesicles. Since blocking endocytosis with temperature-sensitive shibire mutant showed no obvious effect on Dscam dendritic distribution (data not shown; [53]), we favor the model that dynein/dynactin acts to prevent axonal accumulation of Dscam[TM1] by actively moving mistargeted Dscam[TM1]-containing vesicles out of axons by retrograde axonal transport (Figure 7
However, dynein/dynactin is not routinely needed for excluding dendritic proteins from the axons. Since no biological process can be carried out with absolute fidelity, it is conceivable that dendritic molecules of most kinds may accidentally leak into the axons. Some salvage mechanism(s) should exist for actively clearing mislocalized molecules to prevent any significant accumulation in the wrong places. One of the possibilities is that dynein/dynactin mediates retrograde axonal transport and can serve as a general mechanism for removing dendritic molecules out of axons. This hypothesis remains to be tested thoroughly. Nonetheless, blocking dynein/dynactin function did not affect the distribution of two other dendritic markers we checked. Nod-β-gal is a reliable minus-end reporter of microtubules, and misdistribution of Nod-β-gal in MB axons has been shown in short stop mutant clones, in which microtubule polarity is perturbed [47]. Absence of Nod-β-gal from the axons of dynein/dynactin mutant neurons demonstrates that the microtubules in axons remained uniformly polarized with minus ends pointing toward cell bodies, and rules out the possibility that dendritic Dscam became mislocalized due to abnormal microtubule organization. As to Rdl-HA, which, like Dscam[TM1], is a membrane protein, a lack of effect on its somatodendritic distribution indicates that dynein/dynactin is selectively involved in preventing dendritic Dscam from leaking into the axons. Diverse mechanisms may be utilized to efficiently clear different dendritic proteins in axons. Regarding the mechanism(s) of selective transport, directed dendritic targeting apparently requires motor proteins that selectively move cargos toward the dendrites. Since dendrites, but not axons, carry microtubules with minus ends pointing away from cell bodies, potential candidates that underlie directed dendritic targeting include all minus-end-directed microtubule motors. Notably, dynein/dynactin is dispensable to the initial dendritic targeting of Dscam[TM1] or the continuous dendritic restriction of Rdl, arguing against any critical role for minus-end-directed dynein/dynactin in transporting cargos into the dendrites. Other microtubule motors that might support such directional movement include dendrite-specific plus-end-directed motors (e.g. KIF17 and KIF21B), though it remains mysterious how a plus-end-directed motor can be well restricted to dendrites [54], [55]. In theory, forward genetic mosaic screens will ultimately allow us to uncover the diverse mechanisms of dendritic protein targeting. Encouragingly, we have obtained mutants that exhibit different mislocalization phenotypes, further characterization of which should shed additional light on neuron polarity and its underlying cellular/molecular mechanisms. Notably, in DC-B9 mutant clones, mistargeted Dscam[TM1]::GFP existed abundantly in the MB peduncle, preferentially accumulated at the end of the peduncle, but never extended into the axon lobes. This intriguing phenotype suggests presence of distribution barriers not only in the beginning of axons but also at the junction between the proximal axon domain (peduncle) and the distal axon segment (lobe), and implies another possible mechanism for restricting Dscam[TM1] to the dendritic membrane. Furthermore, the functional roles of each subunit of the dynein/dynactin complex have not been fully determined [13]. Although several studies of the dynein light chains in mammalian cells indicate that dynein subunits can be functionally specialized [56], studies in Drosophila show that strong loss-of-function mutations in different dynein/dynactin subunits show extensive overlap in the resulting mutant phenotypes [47], [57]. Our data indicate that Lis1, Dmn, Glued, p24, p25, Dhc64C, Dhc62B, and Dlc90F all participate in the complete function of dynein/dynactin complex in maintaining dendritic distribution of Dscam. This result supports the idea that all the dynein/dynactin subunits work together to fulfill its diverse functions, and loss of any subunits may result in different degrees of similar dynein/dynactin-dysfunctional phenotypes. With respect to Dscam targeting motifs, we have reported that the cytoplasmic juxtamembrane domain of Dscam may dictate its TM-dependent subcellular localization [27]. However, further structure-distribution analysis only allowed us to locate an axonal targeting motif to the cytoplasmic juxtamembrane region of TM2, leaving its dendritic targeting motif(s) still undetermined (unpublished results). In addition, we could not determine using the same system whether any of the mutants recovered here also affects the axonal targeting of Dscam[TM2], since transgenic Dscam[TM2] becomes uniformly distributed upon overexpression following an analogous induction. The involvement of multiple mechanisms in targeting specific Dscams to specific neuronal domains further supports the notion that Dscam isoform compositions in the dendrites versus axons of the same neurons need to be independently regulated, elucidation of the physiological significance of which promises to shed new light on how the brain develops and operates. In summary, we have uncovered a scavenger mechanism for maintaining dendritic distribution of Dscam[TM1] and provide an in vivo model to study neuron polarity and differential protein targeting. On top of the many known functions of dynein/dynactin (including mitosis, vesicular transport, retrograde signaling, neuronal migration), dynein/dynactin helps restrict certain dendritic proteins to the somatodendritic domain of neurons by preventing them from spreading into the axons. Notably, multiple independent mechanisms act together to locate Dscam[TM1] to dendrites; and diverse mechanisms are utilized to target different dendritic proteins to the dendrites. Materials and Methods Generation of UAS-mCD8::RFP The monomeric red fluorescence protein (mRFP) open reading frame [58] was amplified by PCR and was cloned into the mCD8-comtaining pBS [29] with BamHI and XbaI as the cloning sites, generating a new ORF with mRFP fused in frame to the 3′ of mCD8. Then, mCD8::RFP was subcloned into pUAST [59] with XhoI and XbaI as the cloning sites. pUAST-mCD8::RFP transgene was introduced into the fly genome via P element-mediated germline transformation by Genetic Services Inc., MA. Fly Stocks and Crosses For creation of MARCM clones, we crossed UAS-mCD8::RFP; hs-FLP, FRTG13, tubP-GAL80/CyO,Y to either wildtype or mutagenized UAS-Dscam[TM1]::GFP, FRTG13, GAL4-201Y/CyO,Y. UAS-Nod-β-gal [46] or UAS-Rdl-HA [44] was incorporated on third or X chromosomes, respectively, for examining their distribution in MARCM clones. For acute induction by TARGET system, we crossed UAS-Dscam[TM1]::GFP or UAS-mCD8::GFP to tubP-GAL80ts; tubP-GAL80ts; GAL4-OK107. UAS-dominant-negative Glued, P[UAS-GlΔ84], was used to block dynein/dynactin function [42]. To increase copy numbers of P[UAS- GlΔ], we generated another two insertion lines on third chromosome (UAS-GlΔ008m and UAS-GlΔ020m) by hopping out P[UAS-GlΔ84] from second chromosome. Other flies stocks collected for this study include Dmnk16109/CyO (BL-11159), l(2)06496/CyO (BL-12316), Lis-1k13209/CyO (BL-11072), tubP-GAL80ts;Tm2/Tm6B (BL-7019), noc/CyO; tubP-GAL80ts (BL-7018), and RNAi lines from VDRC stock center (Dietzl et al., 2007), including CG8446RNAi (23139), Lis1RNAi (6216), DmnRNAi (23728), p25RNAi (8058), Dhc64CRNAi (28054), Dhc62BRNAi (48153) and Dlc90FRNAi (31750). MARCM-based Genetic Screens and Analysis of MARCM Clones Chemical mutagenesis was conducted in the UAS-Dscam[TM1]::GFP, FRTG13, GAL4-201Y male flies using standard procedure with an EMS concentration of 40 mM [60]. Individual male progeny derived from the mutagenized flies were then crossed with mCD8::RFP; hs-FLP, FRTG13, tubP-GAL80 for MARCM analysis of MB clones. To induce mitotic recombination, newly hatched larvae were heat shocked in a 38°C water bath for one hour and then returned to 25°C. The central nervous systems from wandering third instar larvae were dissected out, fixed and immunostained as previously described [29]. Protein expression was detected by the rabbit anti-GFP Ab (1 300, Molecular Probes) and MB lobes were labeled by the 1D4 mAb (1 80). Immunofluorescent signals were collected by confocal microscopy and then processed using Adobe Photoshop to normalize and exclude the background neurons.Deficiency Mapping and Complementation Testing Following screening, the homozygous lethal mutants were mapped initially by crossing to the second chromosome deficiency kit, provided by the Bloomington Drosophila Stock Center. We performed further fine scale mapping with smaller deficiencies to define the minimal regions containing the lethal mutations. Lines mapped to the similar regions were placed in complementation groups by the complementation testing. Eventually, we tested candidate genes in these regions with available lethal mutant lines from Bloomington. Acute Induction of UAS-transgenes by TARGET system Larvae carrying two copies of tubP-GAL80ts were cultured at the permissive temperature of 18°C since embryogenesis in order to repress GAL4-mediated transcription [50]. Wandering larvae were shifted to 38°C for 30 min, followed by incubation at the non-permissive temperature of 29°C for various periods. Acknowledgments We thank Hung-Hsiang Yu for UAS-mCD8::RFP, Andreas Prokop for UAS-Rdl-HA and UAS-Act5C-GFP, Marcus Allen for UAS- GlΔ, Melissa Rolls for UAS-Apc2-GFP and UAS-homer-GFP, and the Bloomington Stock Center for mutant flies; We thank members of the Lee laboratory for helpful discussions through the entire project. We thank Benjamin Leung, Kimberley Kerr, Lily Jan, Yuh Nung Jan and members of the Jan Lab (University of California, San Francisco) for critical reading of this manuscript. The 1D4 antibody was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242. Footnotes Competing Interests: The authors have declared that no competing interests exist. Funding: The March of Dimes Birth Defects Foundation and the National Institutes of Health References 1. Gu C, Jan YN, Jan LY. A Conserved Domain in Axonal Targeting of Kv1 (Shaker) Voltage-Gated Potassium Channels. Science. 2003;301:646–649. [PubMed] 2. Lim ST, Antonucci DE, Scannevin RH, Trimmer JS. A Novel Targeting Signal for Proximal Clustering of the Kv2.1 K+ Channel in Hippocampal Neurons. Neuron. 2000;25:385–397. [PubMed] 3. Monaghan MM, Trimmer JS, Rhodes KJ. Experimental Localization of Kv1 Family Voltage-Gated K+ Channel {alpha} and {beta} Subunits in Rat Hippocampal Formation. J Neurosci. 2001;21:5973–5983. [PubMed] 4. Hoffman DA, Magee JC, Colbert CM, Johnston D. K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons. Nature. 1997;387:869–875. [PubMed] 5. Wei A, Covarrubias M, Butler A, Baker K, Pak M, et al. K+ current diversity is produced by an extended gene family conserved in Drosophila and mouse. Science. 1990;248:599–603. [PubMed] 6. Stowell JN, Craig AM. Axon/Dendrite Targeting of Metabotropic Glutamate Receptors by Their Cytoplasmic Carboxy-Terminal Domains. Neuron. 1999;22:525–536. [PubMed] 7. Endoh T. Characterization of modulatory effects of postsynaptic metabotropic glutamate receptors on calcium currents in rat nucleus tractus solitarius. Brain Research. 2004;1024:212–224. [PubMed] 8. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 1992;258:597–603. [PubMed] 9. Goldstein LSB, Yang Z. Microtubule-Based Transport Systems in Neurons: The Roles of Kinesins and Dyneins. Annual Review of Neuroscience. 2000;23:39–71. 10. Baas PW, Deitch JS, Black MM, Banker GA. Polarity Orientation of Microtubules in Hippocampal Neurons: Uniformity in the Axon and Nonuniformity in the Dendrite. Proceedings of the National Academy of Sciences. 1988;85:8335–8339. 11. Burack MA, Silverman MA, Banker G. The Role of Selective Transport in Neuronal Protein Sorting. Neuron. 2000;26:465–472. [PubMed] 12. Goldstein LSB, Gunawardena S. Flying Through the Drosophila Cytoskeletal Genome. J Cell Biol. 2000;150:63F–68. 13. Schroer TA. DYNACTIN. Annual Review of Cell and Developmental Biology. 2004;20:759–779. 14. King SJ, Schroer TA. Dynactin increases the processivity of the cytoplasmic dynein motor. 2000;2:20–24. 15. McDonald HB, Stewart RJ, Goldstein LSB. The kinesin-like ncd protein of Drosophila is a minus end-directed microtubule motor. Cell. 1990;63:1159–1165. [PubMed] 16. Saito N, Okada Y, Noda Y, Kinoshita Y, Kondo S, et al. KIFC2 Is a Novel Neuron-Specific C-Terminal Type Kinesin Superfamily Motor for Dendritic Transport of Multivesicular Body-Like Organelles. Neuron. 1997;18:425–438. [PubMed] 17. Garrido JJ, Fernandes F, Giraud P, Mouret I, Pasqualini E, et al. Identification of an axonal determinant in the C-terminus of the sodium channel Nav1.2. EMBO J. 2001;20:5950–5961. [PubMed] 18. Sampo B, Kaech S, Kunz S, Banker G. Two Distinct Mechanisms Target Membrane Proteins to the Axonal Surface. Neuron. 2003;37:611–624. [PubMed] 19. Low S, Chapin S, Weimbs T, Komuves L, Bennett M, et al. Differential localization of syntaxin isoforms in polarized Madin-Darby canine kidney cells. Mol Biol Cell. 1996;7:2007–2018. [PubMed] 20. Horton AC, Ehlers MD. Neuronal Polarity and Trafficking. Neuron. 2003;40:277–295. [PubMed] 21. Rivera JF, Ahmad S, Quick MW, Liman ER, Arnold DB. An evolutionarily conserved dileucine motif in Shal K+ channels mediates dendritic targeting. Nature Neuroscience. 2003;6:243–250. 22. Matthews BJ, Kim ME, Flanagan JJ, Hattori D, Clemens JC, et al. Dendrite Self-Avoidance Is Controlled by Dscam. Cell. 2007;129:593–604. [PubMed] 23. Schmucker D, Clemens JC, Shu H, Worby CA, Xiao J, et al. Drosophila Dscam Is an Axon Guidance Receptor Exhibiting Extraordinary Molecular Diversity. Cell. 2000;101:671–684. [PubMed] 24. Soba P, Zhu S, Emoto K, Younger S, Yang S-J, et al. Drosophila Sensory Neurons Require Dscam for Dendritic Self-Avoidance and Proper Dendritic Field Organization. Neuron. 2007;54:403–416. [PubMed] 25. Wang J, Zugates CT, Liang IH, Lee C-HJ, Lee T. Drosophila Dscam Is Required for Divergent Segregation of Sister Branches and Suppresses Ectopic Bifurcation of Axons. Neuron. 2002;33:559–571. [PubMed] 26. Wang J, Ma X, Yang JS, Zheng X, Zugates CT, et al. Transmembrane/Juxtamembrane Domain-Dependent Dscam Distribution and Function during Mushroom Body Neuronal Morphogenesis. Neuron. 2004;43:663–672. [PubMed] 27. Shi L, Yu H-H, Yang JS, Lee T. Specific Drosophila Dscam Juxtamembrane Variants Control Dendritic Elaboration and Axonal Arborization. J Neurosci. 2007;27:6723–6728. [PubMed] 28. Lee T, Lee A, Luo L. Development of the Drosophila mushroom bodies: sequential generation of three distinct types of neurons from a neuroblast. Development. 1999;126:4065–4076. [PubMed] 29. Lee T, Luo L. Mosaic Analysis with a Repressible Cell Marker for Studies of Gene Function in Neuronal Morphogenesis. Neuron. 1999;22:451–461. [PubMed] 30. Lee T, Marticke S, Sung C, Robinow S, Luo L. Cell-Autonomous Requirement of the USP/EcR-B Ecdysone Receptor for Mushroom Body Neuronal Remodeling in Drosophila. Neuron. 2000;28:807–818. [PubMed] 31. Wang J, Lee C-HJ, Lin S, Lee T. Steroid hormone-dependent transformation of polyhomeotic mutant neurons in the Drosophila brain. Development. 2006;133:1231–1240. [PubMed] 32. Zheng X, Wang J, Haerry TE, Wu AY-H, Martin J, et al. TGF-[beta] Signaling Activates Steroid Hormone Receptor Expression during Neuronal Remodeling in the Drosophila Brain. Cell. 2003;112:303–315. [PubMed] 33. Zhu S, Lin S, Kao C-F, Awasaki T, Chiang A-S, et al. Gradients of the Drosophila Chinmo BTB-Zinc Finger Protein Govern Neuronal Temporal Identity. Cell. 2006;127:409–422. [PubMed] 34. Zhu S, Perez R, Pan M, Lee T. Requirement of Cul3 for Axonal Arborization and Dendritic Elaboration in Drosophila Mushroom Body Neurons. J Neurosci. 2005;25:4189–4197. [PubMed] 35. Liu Z, Steward R, Luo L. Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transport. Nature Cell Biology. 2000;2:776–783. 36. Reiner O, Carrozzo R, Shen Y, Wehnert M, Faustinella F, et al. Isolation of a Miller-Dicker lissencephaly gene containing G protein [beta]-subunit-like repeats. Nature. 1993;364:717–721. [PubMed] 37. Swan A, Nguyen T, Suter B. Drosophila Lissencephaly-1 functions with Bic-D and dynein in oocyte determination and nuclear positioning. Nature Cell Biology. 1999;1:444–449. 38. Clark SW, Rose MD. Alanine Scanning of Arp1 Delineates a Putative Binding Site for Jnm1/Dynamitin and Nip100/p150Glued. Mol Biol Cell. 2005;16:3999–4012. [PubMed] 39. Puls I, Jonnakuty C, LaMonte BH, Holzbaur ELF, Tokito M, et al. Mutant dynactin in motor neuron disease. Nature Genetics. 2003;33:455–456. [PubMed] 40. Didelot G, Molinari F, Tchenio P, Comas D, Milhiet E, et al. Tequila, a Neurotrypsin Ortholog, Regulates Long-Term Memory Formation in Drosophila. Science. 2006;313:851–853. [PubMed] 41. Dietzl G, Chen D, Schnorrer F, Su K-C, Barinova Y, et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature. 2007;448:151–156. [PubMed] 42. Allen MJ, Shan X, Caruccio P, Froggett SJ, Moffat KG, et al. Targeted Expression of Truncated Glued Disrupts Giant Fiber Synapse Formation in Drosophila. J Neurosci. 1999;19:9374–9384. [PubMed] 43. Rolls M, Satoh D, Clyne P, Henner A, Uemura T, et al. Polarity and intracellular compartmentalization of Drosophila neurons. Neural Development. 2007;2:7. [PubMed] 44. Sanchez-Soriano N, Bottenberg W, Fiala A, Haessler U, Kerassoviti A, et al. Are dendrites in Drosophila homologous to vertebrate dendrites? Developmental Biology. 2005;288:126–138. [PubMed] 45. Clark I, Jan L, Jan Y. Reciprocal localization of Nod and kinesin fusion proteins indicates microtubule polarity in the Drosophila oocyte, epithelium, neuron and muscle. Development. 1997;124:461–470. [PubMed] 46. Lee T, Winter C, Marticke SS, Lee A, Luo L. Essential Roles of Drosophila RhoA in the Regulation of Neuroblast Proliferation and Dendritic but Not Axonal Morphogenesis. Neuron. 2000;25:307–316. [PubMed] 47. Reuter JE, Nardine TM, Penton A, Billuart P, Scott EK, et al. A mosaic genetic screen for genes necessary for Drosophila mushroom body neuronal morphogenesis. Development. 2003;130:1203–1213. [PubMed] 48. Koonce MP, Samso M. Of rings and levers: the dynein motor comes of age. Trends in Cell Biology. 2004;14:612–619. [PubMed] 49. Pilling AD, Horiuchi D, Lively CM, Saxton WM. Kinesin-1 and Dynein Are the Primary Motors for Fast Transport of Mitochondria in Drosophila Motor Axons. Mol Biol Cell. 2006;17:2057–2068. [PubMed] 50. McGuire SE, Le PT, Osborn AJ, Matsumoto K, Davis RL. Spatiotemporal Rescue of Memory Dysfunction in Drosophila. Science. 2003;302:1765–1768. [PubMed] 51. Kurusu M, Awasaki T, Masuda-Nakagawa LM, Kawauchi H, Ito K, et al. Embryonic and larval development of the Drosophila mushroom bodies: concentric layer subdivisions and the role of fasciclin II. Development. 2002;129:409–419. [PubMed] 52. McGrail M, Gepner J, Silvanovich A, Ludmann S, Serr M, et al. Regulation of cytoplasmic dynein function in vivo by the Drosophila Glued complex. J Cell Biol. 1995;131:411–425. [PubMed] 53. Kim Y-T, Wu C-F. Allelic Interactions at the Shibire Locus of Drosophila: Effects on Behavior. Journal of Neurogenetics. 1990;7:1–14. [PubMed] 54. Marszalek JR, Weiner JA, Farlow SJ, Chun J, Goldstein LSB. Novel Dendritic Kinesin Sorting Identified by Different Process Targeting of Two Related Kinesins: KIF21A and KIF21B. J Cell Biol. 1999;145:469–479. [PubMed] 55. Setou M, Nakagawa T, Seog D-H, Hirokawa N. Kinesin Superfamily Motor Protein KIF17 and mLin-10 in NMDA Receptor-Containing Vesicle Transport. Science. 2000;288:1796–1802. [PubMed] 56. Tai AW, Chuang J-Z, Bode C, Wolfrum U, Sung C-H. Rhodopsin's Carboxy-Terminal Cytoplasmic Tail Acts as a Membrane Receptor for Cytoplasmic Dynein by Binding to the Dynein Light Chain Tctex-1. Cell. 1999;97:877–887. [PubMed] 57. Whited JL, Cassell A, Brouillette M, Garrity PA. Dynactin is required to maintain nuclear position within postmitotic Drosophila photoreceptor neurons. Development. 2004;131:4677–4686. [PubMed] 58. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, et al. A monomeric red fluorescent protein. Proceedings of the National Academy of Sciences. 2002;99:7877–7882. 59. Brand A, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118:401–415. [PubMed] 60. Lewis EB, Bacher F. Method of feeding ethylmethane sulfonate (EMS) to Drosophila males. Drosoph. Inf. Serv. 1968;43:193. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Science. 2003 Aug 1; 301(5633):646-9.
[Science. 2003]J Neurosci. 2001 Aug 15; 21(16):5973-83.
[J Neurosci. 2001]Nature. 1997 Jun 26; 387(6636):869-75.
[Nature. 1997]Science. 1990 May 4; 248(4955):599-603.
[Science. 1990]Neuron. 1999 Mar; 22(3):525-36.
[Neuron. 1999]Neuron. 2000 May; 26(2):465-72.
[Neuron. 2000]Cell. 1990 Dec 21; 63(6):1159-65.
[Cell. 1990]Neuron. 1997 Mar; 18(3):425-38.
[Neuron. 1997]EMBO J. 2001 Nov 1; 20(21):5950-61.
[EMBO J. 2001]Neuron. 2003 Feb 20; 37(4):611-24.
[Neuron. 2003]Mol Biol Cell. 1996 Dec; 7(12):2007-18.
[Mol Biol Cell. 1996]Neuron. 1999 Mar; 22(3):525-36.
[Neuron. 1999]Neuron. 2003 Oct 9; 40(2):277-95.
[Neuron. 2003]Cell. 2007 May 4; 129(3):593-604.
[Cell. 2007]Neuron. 2002 Feb 14; 33(4):559-71.
[Neuron. 2002]Neuron. 2004 Sep 2; 43(5):663-72.
[Neuron. 2004]J Neurosci. 2007 Jun 20; 27(25):6723-8.
[J Neurosci. 2007]Development. 1999 Sep; 126(18):4065-76.
[Development. 1999]Neuron. 1999 Mar; 22(3):451-61.
[Neuron. 1999]Neuron. 2002 Feb 14; 33(4):559-71.
[Neuron. 2002]Neuron. 2000 Dec; 28(3):807-18.
[Neuron. 2000]J Neurosci. 2005 Apr 20; 25(16):4189-97.
[J Neurosci. 2005]Mol Biol Cell. 2005 Sep; 16(9):3999-4012.
[Mol Biol Cell. 2005]Nat Genet. 2003 Apr; 33(4):455-6.
[Nat Genet. 2003]J Neurosci. 2007 Jun 20; 27(25):6723-8.
[J Neurosci. 2007]Science. 2006 Aug 11; 313(5788):851-3.
[Science. 2006]Nature. 2007 Jul 12; 448(7150):151-6.
[Nature. 2007]J Neurosci. 1999 Nov 1; 19(21):9374-84.
[J Neurosci. 1999]Neural Dev. 2007 Apr 30; 2():7.
[Neural Dev. 2007]Dev Biol. 2005 Dec 1; 288(1):126-38.
[Dev Biol. 2005]Development. 1997 Jan; 124(2):461-70.
[Development. 1997]Development. 2003 Mar; 130(6):1203-13.
[Development. 2003]Neuron. 2000 Dec; 28(3):807-18.
[Neuron. 2000]Neural Dev. 2007 Apr 30; 2():7.
[Neural Dev. 2007]Dev Biol. 2005 Dec 1; 288(1):126-38.
[Dev Biol. 2005]Neuron. 2000 May; 26(2):465-72.
[Neuron. 2000]Trends Cell Biol. 2004 Nov; 14(11):612-9.
[Trends Cell Biol. 2004]Mol Biol Cell. 2006 Apr; 17(4):2057-68.
[Mol Biol Cell. 2006]Science. 2003 Dec 5; 302(5651):1765-8.
[Science. 2003]Development. 2002 Jan; 129(2):409-19.
[Development. 2002]J Cell Biol. 1995 Oct; 131(2):411-25.
[J Cell Biol. 1995]J Neurogenet. 1990 Nov; 7(1):1-14.
[J Neurogenet. 1990]Development. 2003 Mar; 130(6):1203-13.
[Development. 2003]J Cell Biol. 1999 May 3; 145(3):469-79.
[J Cell Biol. 1999]Science. 2000 Jun 9; 288(5472):1796-802.
[Science. 2000]Cell. 1999 Jun 25; 97(7):877-87.
[Cell. 1999]Development. 2003 Mar; 130(6):1203-13.
[Development. 2003]Development. 2004 Oct; 131(19):4677-86.
[Development. 2004]J Neurosci. 2007 Jun 20; 27(25):6723-8.
[J Neurosci. 2007]Neuron. 1999 Mar; 22(3):451-61.
[Neuron. 1999]Development. 1993 Jun; 118(2):401-15.
[Development. 1993]Neuron. 2000 Feb; 25(2):307-16.
[Neuron. 2000]Dev Biol. 2005 Dec 1; 288(1):126-38.
[Dev Biol. 2005]J Neurosci. 1999 Nov 1; 19(21):9374-84.
[J Neurosci. 1999]Neuron. 1999 Mar; 22(3):451-61.
[Neuron. 1999]Science. 2003 Dec 5; 302(5651):1765-8.
[Science. 2003]